[
    [
        {
            "time": "2018-08-14",
            "original_text": "【中投早知道】沪深上市公司18年8月13日晚间上市公司重要公告上海医药：盐酸氟西汀胶囊通过仿制药一致性评价",
            "features": {
                "keywords": [
                    "沪深上市公司",
                    "重要公告",
                    "上海医药",
                    "盐酸氟西汀胶囊",
                    "仿制药一致性评价"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【中投早知道】沪深上市公司18年8月13日晚间上市公司重要公告上海医药：盐酸氟西汀胶囊通过仿制药一致性评价",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]